CIPDAPLA 10 TAB

Dapagliflozin, an SGLT2 inhibitor from the antidiabetic class, is clinically used to manage type 2 diabetes mellitus, heart failure (with reduced ejection fraction), and chronic kidney disease by promoting urinary glucose excretion and improving cardiorenal outcomes.